Anti-tumor-promoting effects of glycoglycerolipid analogues on two-stage mouse skin carcinogenesis

Four glycoglycerolipid analogues, 1-O-hexanoyl-2-O-beta -D-glucopyranosyl-s n-glycerol (1), 1-O-hexanoyl-2-O-beta -D-galactopyranosyl-sn-glycerol (2), 2-O-(6-O-hexnnoyl-beta -D-galactopyranosyl)-sn-glycerol (3) and 2-O-(6-O-he xanoyl-alpha -D-galacto pyranosyl)-sn-glycerol (4), potent in vitro inhibit ors of 12-O-tetradecanoylphorbol-13-acetate (TPA) induced Epstrin-Ban virus early antigen (EBV-EA) activation, were submitted to an in vivo two-stage mouse skin carcinogenesis test, using dimethylbenz[a]anthracene (DMBA) and TPA. The study was extended to two deacylated galactosylglycerol structures , 1-O-beta -D-galactopyranosyl-sn-glycerol (5) and 3-O-beta -D-galactopyran osyl-sn-glycerol (6). All the tested compounds exhibited remarkable anti-tu mor-promoting effects on mouse skin tumor promotion, the 1-hexanoate 2 bein g the most active among the glycoglycerolipids until now studied. (C) 2000 Elsevier science Ireland Ltd. All rights reserved.